It is thought that both helper and effector functions of CD4+ T cells contribute to protective immunity to blood stage malaria infection. However, malaria infection does not induce long-term immunity and its mechanisms are not defined. In this study, we show that protective parasite-specific CD4+ T cells were depleted after infection with both lethal and nonlethal species of rodent Plasmodium. It is further shown that the depletion is confined to parasite-specific T cells because (a) ovalbumin (OVA)-specific CD4+ T cells are not depleted after either malaria infection or direct OVA antigen challenge, and (b) the depletion of parasite-specific T cells during infection does not kill bystander OVA-specific T cells. A significant consequence of the depletion of malaria parasite–specific CD4+ T cells is impaired immunity, demonstrated in mice that were less able to control parasitemia after depletion of transferred parasite-specific T cells. Using tumor necrosis factor (TNF)-RI knockout– and Fas-deficient mice, we demonstrate that the depletion of parasite-specific CD4+ T cells is not via TNF or Fas pathways. However, in vivo administration of anti–interferon (IFN)-γ antibody blocks depletion, suggesting that IFN-γ is involved in the process. Taken together, these data suggest that long-term immunity to malaria infection may be affected by an IFN-γ–mediated depletion of parasite-specific CD4+ T cells during infection. This study provides further insight into the nature of immunity to malaria and may have a significant impact on approaches taken to develop a malaria vaccine.
Skip Nav Destination
Article navigation
1 April 2002
Article|
April 01 2002
The Mechanism and Significance of Deletion of Parasite-specific CD4 + T Cells in Malaria Infection
Huji Xu,
Huji Xu
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Jiraprapa Wipasa,
Jiraprapa Wipasa
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Huaru Yan,
Huaru Yan
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Ming Zeng,
Ming Zeng
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Morris O. Makobongo,
Morris O. Makobongo
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Fred D. Finkelman,
Fred D. Finkelman
2Division of Immunology, University of Cincinnati College of Medicine, Cincinnati, OH 45267
3Cincinnati Veterans Administration, Medical Center, Cincinnati, OH 45220
Search for other works by this author on:
Anne Kelso,
Anne Kelso
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Michael F. Good
Michael F. Good
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Search for other works by this author on:
Huji Xu
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Jiraprapa Wipasa
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Huaru Yan
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Ming Zeng
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Morris O. Makobongo
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Fred D. Finkelman
2Division of Immunology, University of Cincinnati College of Medicine, Cincinnati, OH 45267
3Cincinnati Veterans Administration, Medical Center, Cincinnati, OH 45220
Anne Kelso
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Michael F. Good
1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Queensland 4029, Australia
Address correspondence to Michael F. Good, The Queensland Institute of Medical Research, The Bancroft Centre, P.O. Royal Brisbane Hospital, Queensland 4029, Australia. Phone: 61-7-3362-0266; Fax: 61-7-3362-0110; E-mail: [email protected]
*
Abbreviations used in this paper: B cell KO mice, C57BL/6J-μm chain knockout mice; CFSE, 5- and 6-carboxyfluorescein diacetate succinimidyl ester; EMEM, Eagle's minimal essential medium; MSP119, merozoite surface protein 1; pRBC, parasitized red blood cell; TUNEL, TdT-mediated dUTP nick-end labeling.
Received:
July 06 2001
Revision Received:
February 04 2002
Accepted:
February 15 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (7): 881–892.
Article history
Received:
July 06 2001
Revision Received:
February 04 2002
Accepted:
February 15 2002
Citation
Huji Xu, Jiraprapa Wipasa, Huaru Yan, Ming Zeng, Morris O. Makobongo, Fred D. Finkelman, Anne Kelso, Michael F. Good; The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection . J Exp Med 1 April 2002; 195 (7): 881–892. doi: https://doi.org/10.1084/jem.20011174
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement